Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.

Salem JE, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, Gobert A, Spano JP, Balko JM, Bonaca MP, Roden DM, Johnson DB, Moslehi JJ
Lancet Oncol. 2018 19 (12): 1579-1589

PMID: 30442497 · PMCID: PMC6287923 · DOI:10.1016/S1470-2045(18)30608-9

MeSH Terms (19)

Adult Adverse Drug Reaction Reporting Systems Aged Aged, 80 and over Antineoplastic Agents, Immunological Bayes Theorem Cardiotoxicity Cardiovascular Diseases Databases, Factual Female Humans Immunotherapy Male Middle Aged Pharmacovigilance Retrospective Studies Risk Assessment Risk Factors Time Factors

Connections (2)

This publication is referenced by other Labnodes entities: